A comparison of the efficacy and safety of direct oral anticoagulants with low molecular weight heparin for venous thromboembolism prophylaxis after total hip arthroplasty : a systematic review and meta-analysis

Bone Joint J. 2026 Nov 1;108-B(11):1294-1304. doi: 10.1302/0301-620X.108B11.BJJ-2026-0451.R2.ABSTRACTAIMS: To evaluate differences in the efficacy and safety of low molecular weight heparin (LMWH) and direct oral anticoagulants (DOACs) used for venous thromboembolism (VTE) prophylaxis after elective

H Hasan R Mohammad

Adjunctive fucoidan, fucoxanthin, and l-carnitine mitigate albuminuria and preserve eGFR over a 12-week treatment period in diabetic kidney disease: A translational study and proof-of-concept randomized clinical trial

Phytomedicine. 2026 Oct 21;162:158870. doi: 10.1016/j.phymed.2026.158870. Online ahead of print.ABSTRACTBACKGROUND AND AIM: Standard therapies for diabetic kidney disease (DKD) reduce albuminuria but trigger an acute eGFR decline, limiting clinical initiation. We evaluated whether a standardized mar

C Cheng-Hsien Chen

Frailty in Older Adults with Heart Failure

Curr Heart Fail Rep. 2026 Oct 31;23(1):53. doi: 10.1007/s11897-026-00785-6.ABSTRACTPURPOSE OF REVIEW: Heart failure (HF) and frailty are increasingly prevalent with population aging, frequently coexist, and share pathophysiological mechanisms. This review summarizes recent evidence on shared biologi

M Miroslava Valentová